Conferences

15–20 July 2012, Davidson, NC, USA
Transglutaminases in Human Disease Processes

Transglutaminases are a family of structurally and functionally related proteins that are widely distributed in all living organisms. There has been a recent surge in findings supporting that dysregulated expression and function of transglutaminases contribute to pathological conditions, such as cancer metastasis, tissue fibrosis, celiac disease, neurodegenerative disorders, and diseases related to defective assembly of the stratum corneum of the skin. The 2nd Gordon Conference on "Transglutaminases in Human Disease Processes" will focus on this rapidly expanding field. The meeting will cover cutting-edge research on the biology of transglutaminases and their role in health and disease processes. Sessions will cover recent advances relating to the following topics:

  • Transglutaminases in growth, development, and differentiation
  • Transglutaminases as regulators of cell survival and cell death modalities
  • Transglutaminases in cancer development and metastasis processes
  • Transglutaminases and cell signal transduction
  • Transglutaminases in physiological and pathological inflammation
  • Transglutaminases in celiac, neurodegeneration, and cardiovascular disease
  • Transglutaminases-induced matrix remodeling in health and disease
  • Transglutaminases as therapeutic targets
  • Transglutaminases as a tool for biotechnology

http://www.grc.org/programs.aspx?year=2012&program=transgluta

Back to TopTop